| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹25.25 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹25.25 Cr |
| Fresh Issue | ₹23.86 Cr |
| Face Value | βΉ10 Per Equity Share |
| Price Band | βΉ52.00-55.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544327 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Shreni Shares Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in 1996, Technichem Organics Limited is engaged in the business of manufacturing a various range of chemicals, Speciality Chemicals, Pigment & Dye Intermediates and Air Oxidation Chemistry.
The company serves a variety of industries, including pharmaceuticals, agriculture, coatings, pigments, dyes, and more, showcasing the versatility of its products.
They focus on delivering high-quality, precise chemical compounds and raw materials tailored for agrochemical, coating, pharma, dye, pigment, and specialty chemical sectors, with all manufacturing done in-house.
The company has an annual manufacturing capacity of 950,000 kg. It operates three plants at its facility, which covers an area of 26,079 square meters. The company has a global presence, operating in approximately 11 countries, with significant exports directed to China.
The company focuses on quality, environment, health, and safety, recognizing that maintaining high product standards is key to growth. Across its manufacturing facilities, the company has implemented quality systems covering all business processes, from manufacturing and supply chain to product delivery.
Business Model:
As of June 30, 2024, the company has 72 employees.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (βΉ Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure requirements of the Company towards setting up of a new plant named as βPlant β4β; | 7.04 |
| 2 | Repayment or prepayment, in full or in part, of certain borrowings availed by the Company from banks, financial institutions and non-banking financial companies; | 10.24 |
| 3 | General corporate purposes; | 5.26 |
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 57.43 | 52.47 | 44.25 | 44.17 |
| Total Income | 14.88 | 46.97 | 51.02 | 67.79 |
| Profit After Tax | 1.40 | 4.73 | 1.73 | 3.42 |
| NET Worth | 21.03 | 19.62 | 14.89 | 13.16 |
| Reserves and Surplus | 8.29 | 17.07 | 12.35 | 10.62 |
| Total Borrowing | 16.58 | 17.64 | 15.62 | 10.17 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 27.39% |
| ROCE | 22.57% |
| Debt / Equity | 0.90% |
| RoNW | 24.09% |
| PAT Margin | 10.19% |
| Price to Book Value | 3.57 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (βΉ) | 3.71 | 2.73 |
| P/E (x) | 14.81 | 20.15 |
| Promoter Holding | 97.64% | 71.77% |
| Market Cap | βΉ95.27 Cr. | |